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 Peripheral injection of α-MSH promotes glucagon secretion in POMC knockout 
mice, suggesting the role of α-MSH in regulation of pancreatic α cells. However, the 
underlying mechanisms remain unknown. This study investigated the stimulatory effect 
of α-MSH on mice pancreatic α cell line αTC1-6 cells in cell signaling pathway as well 
as glucagon secretion. In normal level of glucose, application of α-MSH stimulated L-
type Ca2+ current induced Ca2+ induced Ca2+ release (CICR) and membrane 
hyperpolarization. Increase of [cAMP]c was also observed when α-MSH was applied 
with IBMX. Acute hypoglycemia-induced CICR via N- and L-type Ca2+ channels was 
overridden by typical α-MSH response. Hypoglycemia with IBMX also triggered Ca2+-
stimulated cAMP production.  In the presence of α-MSH, insulin failed to inhibit acute 
hypoglycemia-induced CICR. Finally, stimulation of α-MSH increased glucagon 
secretion significantly. These findings indicate that α-MSH promotes glucagon secretion 
in αTC1-6 cells by elevating micro-regional [cAMP]c and [Ca2+]c. 
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Regulation of blood glucose 
      The homeostasis of blood glucose is regulated by hormones secreted from 
the pancreatic islets of Langerhans. In general, insulin and glucagon together 
maintain the circulating glucose level in a narrow range from 5mM to 7mM, by 
regulating the uptake and release of glucose from hepatic cells, as well as regulate 
metabolic rate. During a fast, a drop of blood glucose below the normal level 
triggers the secretion of glucagon from pancreatic α cells; glucagon stimulates the 
breakdown of glycogen stored in liver cells so that release of glucose compensates 
the loss in the bloodstream. On the other hand, after meals, blood glucose could 
temporarily reach as high as 15mM. In response, β cells secrete insulin thus 
accelerating glucose uptake and glycogen synthesis in liver cells, and suppressing 
circulating glucose concentration to normal level.  
      In type I and type II Diabetes mellitus, pancreatic β cells are either 
destroyed or dysfunctional by secreting deficient amount of insulin in response to 
high plasma glucose levels, or insulin resistance has been developed. Recently, it 
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was noticed that impaired α cell function is always associated with diabetes. For 
example, hypersecretion of glucagon during hyperglycemia worsens the symptoms 
(Jiang and Zhang, 2003). In the treatment of diabetes, injection of insulin caused 
hypoglycemia suggesting that counter-regulatory response of glucagon secretion 
was also impaired in both type I and type II diabetic patients (Cryer, 2002).              
Glucose regulated insulin secretion 
      β cells possess an intrinsic glucose-sensing system in response to 
hyperglycemia, and the mechanism has been well studied for decades (Figure 1). 
Glucose transporter GLUT2 moves extracellular glucose across the cell membrane, 
and then glycolysis occurs in the cytoplasm (Rorsman and Renstrom, 2003). In 
mitochondria, Acetyl Co-A enters the TCA cycle, and electrons are passing through 
electron transport chain, resulting in the production of ATP. Consequently, the 
increase of cytoplasmic ATP/ADP ratio causes the closure of ATP-sensitive 
potassium channels (KATP channels), which at rest, remain open contributing to a 
resting potassium conduction. Closing KATP channels triggers membrane 
depolarization. Since β cells express voltage-gated L-type calcium channels in 
close apposition to dense core vesicle docking regions, membrane depolarization 
causes voltage-gated Ca2+ channels to open, Ca2+ influx, and exocytosis of dense 
core vesicles (DCV) containing insulin and Zn2+ (Aizawa et al., 1994). 
 
 
Figure 1. Glucose dependent insulin secretion in β cell. (Holz, 2004)       
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GLP-1 and cAMP modulated insulin secretion 
      In addition to their intrinsic mechanism in response to elevated glucose, β 
cells are also regulated by incretin hormones, one of which is glucagon-like 
peptide1 (GLP-1). Encoded by proglucagon gene, GLP-1 is mainly synthesized by 
enteroendocrine L cells of the small intestine and released into blood stream during 
the ingestion of fat, protein hydrolysate, or when glucose enters duodenum. GLP-1 
augments insulin secretion of β cells through a G protein coupled receptor. GLP-1 
does have an effect on type II diabetic patients, therefore making it a potential 
therapeutic target for diabetes treatments (Doyle et al., 2007).  
      In rat islets, GLP-1R is solely expressed in β cells (Orskov et al., 1991), 
coupled with Gαs subunit. Binding of GLP-1 leads to dissociation of Gαs subunit, 
activation of adenylate cyclase, and cAMP production. Second messenger cAMP 
participates in multiple cell signaling pathways, such as protein kinase A and Epac, 
both of which produce an increase of insulin secretion. Type I and type II 
regulatory subunit of PKA have been found in rat islet tissue (Sugden et al., 1979); 
however, it is not clear which one is expressed in human β cells yet. Lester and 
colleagues demonstrated that AKAP inhibitor Ht31 blocked GLP-1 induced insulin 
secretion (Lester et al., 1997), indicating the presence of RII subunit and that 
anchoring of PKA plays a role in GLP-1 signaling. In addition, three different PKA 
catalytic subunits Cα, Cβ and Cγ have been detected in mouse cell line βTC-6, by 
means of confocal microscopy (Gao et al., 2002). The second class of cAMP- 
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activated proteins is cAMP-regulated guanine nucleotide exchange factors, also 
known as Epac. Two major isoforms, Epac 1 and Epac 2, have been found in rat 
islets and β cell lines MIN-6 and HIT-T15 (Leech et al., 2000).  
      In terms of cAMP regulation of calcium, cAMP induced ER Ca2+ store 
release, and resultant Ca2+-dependent insulin secretion, currently, there are two 
major opposing hypotheses: PKA dependent pathway versus PKA independent 
pathway (Epac mediated pathway). GLP-1 activates ryanodine receptor (RyR) 
through Epac 2 (Kang et al., 2003), meanwhile, opening of inositol 1, 4, 5 
triphosphate receptors (IP3R) in response to GLP-1 is PKA dependent (Tsuboi et al., 
2003). Activation of RyR and IP3R causes ER Ca2+ store release, which both 
possibly cause fast dense core vesicle exocytosis. A 65-kDa vesicle-associated form 
of SUR, a subunit of KATP channel, was found via direct interaction with Epac2 
mediating exocytosis of insulin granules, supporting Epac dependent mechanism 
(Eliasson et al., 2003). In contrast, a PKA-dependent model was postulated, which 
emphasized the importance of ATP actions on [Ca2+]c and KATP channels, suggesting 
that PKA phosphorylation is also required in GLP-1 induced insulin secretion 
(Kasai et al., 2002). It is important to note that cAMP potentiates Ca2+-induced 




Complications in mechanisms of glucagon secretion  
      As the major counterpart of insulin-secreting β cells, pancreatic α cells 
secrete glucagon during hypoglycemia to induce hepatic glucose output. Compared 
to well-interpreted insulin secretion, the mechanism underlying glucagon secretion 
is poorly understood, especially at the molecular level. This is due to several 
complications confronted when studying α cells.  
      α cells only comprise 15%-20% cell composition of Langerhans islet 
(~30% in human islets). Clear anatomical subdivisions exist in mouse islets: α cells 
are located in the periphery region of islet; while β cells are mainly composed the 
core. The cytoarchitecture of human islets, however, is not well-defined. α, β, and δ 
cells are scattered throughout the islet and closely associated with islet’s 
microcirculation without particular order in alignment along blood vessels (Cabrera 
et al., 2006). Thus, lack of identification pattern within intact islets partly causes 
limitations in deciphering the mechanisms of glucagon secreting α cells.  
      Currently, paradoxes remain in clarifying the role of glucose in glucagon 
secretion. Increase of glucose concentration clearly accelerates glucose metabolism 
and leads to ATP accumulation in both α cells and β cells. However, cytoplasmic 
ATP/ADP ratio in α cells is high at very low glucose levels (Detimary et al., 1998). 
This may explain why α cells express the same KATP channels as β cells, but 
glucagon secretion is stimulated by low level of glucose (<5mM) when β cell 
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activity is highly inhibited. In general, at low glucose, α cells spontaneously fire 
action potentials, which are probably the outcome of low KATP channel activity. 
Exposure of glucose causes low KATP channel activity in β cells which in turn 
release insulin, but in α cells, it is the absence of glucose that inhibits KATP channel 
activity to a same low level (Smith et al., 1990). Selective KATP channel blocker 
tolbutamide completely inhibits KATP channel activity and glucagon secretion at 
high concentration (>10µM), while low concentration of tolbutamide (0.1-1µM) 
stimulates glucagon secretion due to partial closure of KATP channels. Hence, it has 
been proposed that glucose appeared to display dual effects to the same extent in α 
cells, albeit a much weaker inhibition (Macdonald et al., 2007).     
      Intraislet paracrine signals released from β cells and δ cells significantly 
affect α cell activity in hyperglycemia state. In type I diabetes, glucose actually 
stimulates glucagon secretion when β cell function is severely impaired. Likewise, 
recent studies showed glucose stimulates rather than inhibits glucagon secretion in 
FACS-isolated rat α cells (Frankin et al., 2005). α cells are highly sensitive to β cell 
secretory products (Takahashi et al., 2006). They express insulin receptors at the 
similar high level as liver cells do (Franklin et al., 2005) and insulin possibly 
hyperpolarizes α cells through PI3K dependent pathway that opens KATP channels, 
and eventually suppress glucagon secretion (Leung et al., 2006). Moreover, rat islet 
GABA inhibits glucagon secretion by hyperpolarizing α cells via activation of 
GABAA receptor (Wendt et al., 2004). Typically, activation of GABA receptor 
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mediated membrane hyperpolarization is due to the closure of Ca2+ channels or 
opening of K+ channels (Cherubini et al., 1991). GABAB receptor subunits were 
also detected in rat α cells (Braun et al., 2004), but exogenous agonist was unable 
to affect insulin secretion (Wang et al., 2006). Somatostatin released from δ cells is 
another potent inhibitor. Type 2 somatostatin receptors are expressed dominantly in 
α cells, and they are required for the inhibitory action of somatostatin on mouse 
glucagon secretion. So far, there are at least three possible mechanisms proposed 
for somatostatin inhibitory effect on α cells: Gαi-dependent membrane 
hyperpolariztion, Gαi -dependent adenylate cyclase inhibition, and calcineurin 
dependent exocytosis inhibition (Gromada et al., 2007). Recently, it has been 
reported that GABA, inhibitory neurotransmitter, is produced and released from 
pancreatic β cells (Franklin and Wollheim, 2004).  
POMC proteins 
      In mammals, pro-opiomelanocortin (POMC) gene is expressed at relative 
high levels in several different tissues, including hypothalamic neurons, anterior 
and intermediate pituitary, immune system and skin. After being translated, 31kDa 
POMC protein is cleaved by prohormone convertase1 (PC1) thus producing ACTH, 
which in turn, was cut by prohormone convertase2 (PC2) to yield α-melanocyte- 
stimulating hormone (α-MSH) (Figure 2). Other gene products derived from the 
same precursor include CLIP, β-, γ-MSH, β-, γ-lipotropin, and β-endorphin. 
Melanocortin peptides as well as ACTH share an invariant amino acid sequence, 
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His-Phe-Arg-Trp, or “HFRW” motif, which is considered the binding region for 
melanocortin receptors. Over the decades, it has been reported that POMC gene 
products have important roles in regulating the stress response, immune system, 
sexual function, and feeding behavior (Arora et al., 2006).  
 
 




      In mammalian tissues, there are five members identified in the family of 
melanocortin receptors, which all belong to G-protein coupled receptors. MC1R is 
the only one specifically expressed in melanocytes, regulating the pigmentation 
(eumelanin-pheomelanin switch). MC2R found in adrenal cortex mediates 
adrenocorticoid biosynthesis, while MC5R is involved in exocrine secretion. 
MC3R and MC4R play a role in metabolic homeostasis. They are widely 
distributed in CNS and peripheral tissues (Cone, 2006). α-MSH reduces feeding in 
rodents through MC3R and MC4R, when administered centrally. Human and 
murine MC4R mutants displayed obese phenotype with hyperphagia. In contrast, 
MC3R knockout mice were obese with increased fat mass, decreased lean body 
mass, and not hyperphagic, suggesting this kind of obesity is dependent on fat 
intake (Millington, 2007). Except for MC2R, which is only activated by ACTH, all 
the other melanocortin receptors can be stimulated by either ACTH or α-MSH 
(Cone, 2006). Since melanocortin receptors are coupled to Gαs subunit, binding of 
ligand leads to the activation of adenylate cyclase and accumulation of cAMP 
within the target cell.  
POMC knockout mice and the effect of α-MSH  
      Lacking POMC derived peptides, homozygous POMC null mice were obese, 
hyperphagic, and failed to develop adrenal gland. Surprisingly, these mice 
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displayed normal serum insulin and fasted glucose levels, suggesting they were 
able to maintain normal insulin secretion and uptake of glucose. Nevertheless, 
POMC null mice suffered severe hypoglycemia and resultant hypoglycemic shock 
after insulin injection, due to the lack of glucagon secretion. Under this condition, 
they were rescued by peripheral administration of α-MSH, but not ACTH. It was 
also found that injection of α-MSH significantly elevated serum glucagon level 
(Hochgeschwender et al., 2003). To rule out the effect caused by epinephrine or 
corticosterone deficiency, SHU9119, an antagonist of MC4R, was applied to wild 
type mice in insulin tolerance test, and counter-regulatory response was 
significantly blocked two hours after insulin injection by SHU9119. Furthermore, 
administration of SHU9119 significantly undermined plasma glucagon levels in 
wild type female mice 30 minutes after injection (Hochgeschwender and Angleson, 
unpublished data). Collectively, impaired counter-regulatory response together with 
decreased circulating glucagon levels implied an important role of α-MSH in 
stimulating glucagon secretion via MC4R.  
      Immunocytochemistry of human whole islets showed colocalization of 
MC4R positive cells and glucagon positive cells (Figure 3), suggesting MC4R is 
only expressed within glucagon-secreting α cells of human islets. Consistently, 
PCR experiments revealed that MC4R is present in mouse islets and αTC1-6 cells, 
but not in MIN-6 cells and αTC1-9 cells (Lumsden, MS thesis 2008). αTC1-6 cells 
are one of the subclones of a glucagonoma-derived cell line. Since they do not 
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express insulin or somatosatin, αTC1-6 cell line is widely used in the studies of α 
cell gene expression and hormone secretion (McGirr et al., 2005). Thus, we choose 
αTC1-6 cells as the model to examine the ability of α-MSH through MC4R to 
regulate cell signaling and glucagon secretion. The focus of this thesis is to 
determine the mechanism by which MC4R activation controls α cell function. 
 
Figure 3. Immunocytochemistry of human islets. Blue-insulin; green-glucagon; 











MATERIALS AND METHODS 
Cell culture 
      Mouse pancreatic α cell line αTC1-6 cells (obtained from D. Steiner, 
University of Chicago, passage numbers 3-11) were grown in DMEM containing 
15mM glucose, 10% heat inactivated fetal bovine serum, 1.0 mM sodium pyruvate, 
100unit/ml penicillin, 100µg/ml streptomycin, 100µg/ml normacin, and MEM non 
essential amino acids, and maintained in a humidified incubator with 95% air and 
5% CO2 at 37˚C.  
Intracellular Ca2+ imaging 
      Fura-2 loading solution included standard extracellular solution containing: 
140mM NaCl, 2.0mM KCl, 1.0mM MgCl2, 5.0mM CaCl2, 10mM HEPES, 8mM 
D-glucose, and supplemented with 5µM Fura-2 AM (PH adjusted to 7.2). 48 hours 
before calcium imaging, αTC1-6 cells were plated on 35/12mm glass bottom dishes 
coated with 1mg/ml PEI. Growth media were removed and replaced with standard 
extracellular solution with Fura-2 loading solution. Fura-2 was loaded for 30 
minutes at room temperature, and then, was washed three times with fresh standard 
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extracellular solution. Images were acquired by 40X oil immersion objective (Zeiss 
axiovert s100) with an inverted fluorescence microscope equipped with Cooke 
SensiCam CCD camera. 340nm and 380nm excitation filters were used for Fura-2 
dual excitation ratio imaging. Cellular Fura-2 fluorescence was obtained every 
second with 20ms exposure (Bin factor 8×8, neutral density 10%) and analyzed 
using SlideBook software. Emission intensities were background subtracted, and 
data were expressed as 340nm/380nm ratio. Puffing α-MSH was performed 
through pico-spritzer, all applications were 5 sec duration. 
Transfections 
      1.2×106 αTC1-6 cells were transfected with 2µg of plasmid encoding 
CFP-Epac-YFP construct (H84) as described (Ponsioen B. et al., 2004) using Cell 
Line Nucleofector Kit (Amaxa Inc.) with solution L and program A-20. Cells were 
plated into six 35/12mm glass bottom dishes coated with 1mg/ml PEI. Transfection 
efficiencies ranged between 30% and 40%. 
cAMP-FRET measurements 
      48 hours after transfection, imaging experiments were conducted with 
constant perfusion of standard extracellular solution (0.5-1.5ml/min). Dishes were 
placed on an inverted fluorescence microscope with 40X oil immersion objective, 
and excited at 425nm. Emission of CFP and YFP was detected through 470nm and 
530nm filters, controlled by Sutter Lambda 10-2 filter wheel (250ms delay). 
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Images were captured by digital camera with 20 ms exposure at 5-second intervals 
(Bin factor 4×4). Relative fluorescence resonance energy transfer (FRET) was 
expressed as the fluorescent intensity of CFP/YFP. Binding of cAMP to Epac 
induces a conformational change in Epac protein structure, which increases the 
distance between CFP and YFP. Fluorescent emission from CFP increases while 
that from YFP decreases. As a result, the ratio of CFP to YFP increases, indicating 
elevated [cAMP]c levels.    
Membrane potential measurements 
      To monitor cell membrane potential, a membrane potential sensitive dye, 
bis (1,3-dibutylbarbituric acid) trimethine oxonol (bisoxonol) was applied in 
standard external solution. In pre-experiments, we tried to optimize the incubation 
time to allow bisoxonol to penetrate cell membrane and reach equilibrium before 
imaging. Nevertheless, after 50 minutes incubation within 30nM bisoxonol, 
fluorescent intensity is still increasing gradually in αTC1-6 cells. So we took 20 
minutes as the incubation time for bisoxonol and the effect of non-equilibrated 
fluorescent signal was analyzed in the results. 
48 hours before calcium imaging, αTC1-6 cells were plated on 35/12mm 
glass bottom dishes coated with 1mg/ml PEI. Growth media was removed and 
replaced with standard extracellular solution with 30nM bisoxonol. Cells were 
incubated in bisoxonol for 20 minutes at room temperature, and then washed once 
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with standard extracellular solution containing 30nM bisoxonol. Bisoxonol was 
present throughout constant perfusion (0.5-1.5ml/min). Images were acquired by 
40X oil immersion objective with an inverted fluorescence microscope equipped 
with digital camera. Bisoxonol fluorescence was monitored at 520nm every five 
seconds with 3ms exposure (Bin factor 2×2) and analyzed using SlideBook 
software.  
Glucagon secretion enzyme immunoassay 
      Cells were plated in poly-lysine coated 24-well plates and allowed to settle 
down and recover from tryspinization for one day. On the second day after seeded, 
cells were rinsed twice with 8mM glucose standard external solution, and 
preincubated with 8mM glucose standard external solution for 20 minutes, and then 
rinsed again. Cells were then stimulated for 10 to 30 minutes in 55nM 
NDP-α-MSH within standard external solutions containing 2mM or 8mM glucose. 
24 well-plates were centrifuged at 2000rpm for 5 minutes, and then media were 
collected. Secreted glucagon content was assessed by glucagon enzyme 
immunoassay using Glucagon EIA kits (Phoenix Pharmaceuticals Inc.) and Bio-tek 






      To compare differences between controls and experimental treatments, 
statistical differences were determined using unpaired Student’s t-test for equal 






Effects of α-MSH in [cAMP]c production 
Previous studies showed that peripheral injection of α-MSH rescued POMC 
knockout mice from hypoglycemic shock by stimulating glucagon secretion 
(Hochgeschwender et al., 2003), and MC4R receptors were identified by PCR and 
immunohistochemistry studies in mice pancreatic α cells and αTC1-6 cells 
(Lumsden, MS thesis 2008). These results draw attention to the direct action of 
α-MSH on pancreatic α cells. Since all five members of melanocortin receptors are 
coupled to Gαs, which is believed to activate adenylate cyclase, α-MSH may 
modulate α cells glucagon secretion through cAMP-dependent pathway. To 
investigate whether α-MSH affects cAMP formation, FRET was used to evaluate 
[cAMP]c levels in transfected αTC1-6 cells.   
Two days after transfection of cAMP reporter H84, αTC1-6 cells were 
imaged with constant perfusion of standard extracellular solution containing 8mM 
glucose. During 10 minutes stimulation of 55nM α-MSH, changes of [cAMP]c 
levels were not detectable in FRET imaging (Figure 4). However, in the presence of 
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1mM 3-isobutyl-1-methylxanthine (IBMX), a non-specific phosphodiesterase (PDE) 
inhibitor, α-MSH was able to induce [cAMP]c increase (Figure 5). Considering that 
application of IBMX alone did not affect [cAMP]c levels (Figure 6), PDE activity 
was low at resting condition. As a global measurement of [cAMP]c, FRET imaging 
could not detect an increase of [cAMP]c when PDE activity is high. These data 
suggest that α-MSH may stimulate cAMP production in certain micro-domains, and 
cAMP molecules were quickly degraded by neighboring PDE.  
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Figure 4. α-MSH alone didn’t cause changes in FRET signals. 55nM α-MSH was 
 
applied to αTC1-6 cells within standard external solution containing 0.25% BSA 
via constant perfusion. A, individual traces represent single YFP-positive cells. B, 




















































































Figure 5. α-MSH with IBMX induced increase in [cAMP]c. 55nM α-MSH and 
1mM IBMX was applied to αTC1-6 cells within standard external solution 
containing 0.25% BSA via constant perfusion. A, individual traces represent single 































































Figure 6. Application of IBMX didn’t affect [cAMP]c levels of αTC1-6 cells. A, 
individual traces represent single YFP-positive cells. One out of 13 cells showed 
[cAMP]c increase in response to 1µM IBMX. B, average trace of 13 cells plotted 
with error bars. 
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α-MSH as a stimulus for calcium induced calcium release (CICR) 
Because it is known that stimulatory ligands usually induce [Ca2+]c increase, 
and  glucagon secretion is based on Ca2+-dependent exocytosis, Ca2+ imaging with 
fura-2 was performed to determine how α-MSH affects [Ca2+]c levels in αTC1-6 
cells. Within standard external solution containing 8mM glucose, 55nM α-MSH 
stimulated a gradual increase in [Ca2+]c, which reached 150% greater than baseline 
in 10 minutes stimulation. 5-second puffing of 55nM α-MSH also induced a 
gradual [Ca2+]c increase (Figure 7).  
Removal of extracellular Ca2+ completely blocked α-MSH induced [Ca2+]c 
increase (Figure 8), but after a 4-minute stimulation of α-MSH in regular standard 
extracellular solution, removal of extracellular Ca2+ failed to stop continuous 
[Ca2+]c gradual increase, depleted the initial increase, but did not prevent a 
secondary increase phase (Figure 9). These results indicated that α-MSH stimulated 
CICR in αTC1-6 cells.  
Next, voltage-dependent Ca2+ channel blockers were applied to standard 
external solutions to determine availability of different types of Ca2+ channels 
affected by α-MSH. Application of 10µM nifedipine, L-type Ca2+ channel blocker, 
inhibited α-MSH induced [Ca2+]c increase, while 1µM ω-conotoxin failed to block 
CICR, suggesting that initial Ca2+ influx of α-MSH-induced CICR is mainly caused 
by the opening of L-type Ca2+ channels, and Ca2+ influx through N-type Ca2+ 
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channels is present but not big enough to trigger CICR (Figure 10). Consistent with 
the results of zero extracellular Ca2+ experiments, combination of nifedipine and 
ω-conotoxin completely abolished [Ca2+]c increase.  
Inhibitory effect of insulin on αTC1-6 cells was also examined with 
application of α-MSH (Figure 11). In the presence of insulin (100ng/ml), α-MSH 
still induced a gradual increase of [Ca2+]c, but only 30% greater than baseline. This 
demonstrates that insulin could partially inhibit but not abolish α-MSH-induced 
CICR.   
 
Figure 7. α-MSH stimulated a gradual increase of [Ca2+]c. A, individual traces 
represent single cells. B, average trace of 40 cells plotted with error bars. C. 5- 




Figure 8. α-MSH induced CICR was blocked in zero extracellular Ca2+ solution. 
Traces represent the average of 40-50 cells plotted with error bars. A, control: 
α-MSH induced gradual [Ca2+]c increase. B, α-MSH induced [Ca2+]c responses was 





















































Figure 9. α-MSH induced CICR showed in Ca2+-free external solutions. Traces 
represent the average of 40-50 cells plotted with error bars. A, control: α-MSH 
induced gradual [Ca2+]c increase. B, C, different types of [Ca2+]c responses in 





























































Figure 10. Effects of VGCC blockers on α-MSH response. Traces represent the 
average of 40-50 cells plotted with error bars. A, Control: α-MSH induced gradual 
[Ca2+]c increase. B, 10µM nifedipine, L-type Ca2+ channel blocker, was applied 18 
minutes before imaging, and present in all solutions. C, 8 minutes before imaging, 
1µM ω-conotoxin, N-type Ca2+ channel blocker, was applied to dishes and present 
in all solutions with 0.25% BSA. D. 10 minutes before imaging, combination of 
10µM nifedipine and 1µM ω-conotoxin was applied to dishes and present in all 






































Figure 11. Inhibitory effect of insulin in α-MSH induced [Ca2+]c response. Traces 
represent the average of 50-60 cells with error bars. A, control: α-MSH induced 
gradual [Ca2+]c increase. B, 10 minutes before imaging, insulin (100ng/ml) was 
applied to dishes and present in all solutions with 0.25% BSA.  
32 
33 
Effect of α-MSH on cell membrane potential 
In β cells, glucose-mediated depolarization triggers Ca2+-dependent insulin 
secretion. To determine the changes in membrane potential after application of 
α-MSH, bisoxonol, a potential-sensitive fluorescent dye, was used in αTC1-6 cell 
imaging. In response to 55nM α-MSH, bisoxonol fluorescent intensity slowly 
decreased, indicating that cell membranes became hyperpolarized (Figure 12). In 
contrast, AC activator forskolin also increased [cAMP]c and [Ca2+]c, but did not 
hyperpolarize αTC1-6 cells (Imseis MS thesis, 2009). α-MSH induced 
hyperpolarization could be caused by efflux of K+ through opening of K+ channels. 










































Figure 12. Bisoxonol measurements showed that α-MSH hyperpolarized αTC1-6 
cells. A, individual traces represent single cells. B, average trace of 29 cells 




Acute hypoglycemia as a stimulus for CICR 
In intact pancreatic islets, glucagon secretion from α cells is enhanced in 
response to hypoglycemia. Since α cell exocytosis is a Ca2+-dependent process, 
effects of acute hypoglycemia in [Ca2+]c were examined by Ca2+ imaging. A 
decrease in glucose from 8mM to 2mM induced an immediate [Ca2+]c increase, 
which reached a plateau in 2.5 minutes (Figure 13). Unlike the effect of α-MSH on 
αTC1-6 cells, this fast action was highly suppressed by the application of insulin 
(Figure 14).  
Removal of extracellular Ca2+ instantaneously abolished the fast [Ca2+]c 
increase to the baseline level, but a gradual increase showed afterward when cells 
were still in Ca2+-free solution (Figure 15). This demonstrated that drop of glucose 
also induced CICR in α cells. Either nifedipine or ω-conotoxin partially inhibited 
acute hypoglycemia induced [Ca2+]c increase by 50% reduction in amplitude, and 
when applied together, nifedipine and ω-conotoxin fully removed [Ca2+]c increase 
(Figure 16). These indicated that in response to the drop of glucose concentrations, 
extracellular Ca2+ influx went through both L-type and N-type Ca2+ channels to 
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Figure 13. Acute hypoglycemia-induced fast [Ca2+]c increase. A, individual traces 













































Figure 14. Insulin strongly inhibited acute hypoglycemia-induced fast [Ca2+]c 
increase. Traces represent the average of 50-60 cells plotted with error bars. A, 
Control: acute hypoglycemia-induced fast [Ca2+]c increase. B, 4 minutes before 
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Figure 15. CICR showed in Ca2+ free extracellular solutions. A, individual traces 
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Figure 16. Effects of VGCC blockers on [Ca2+]c response to acute hypoglycemia. 
Traces represent the average of 50-60 cells plotted with error bars. A, Control: 
acute hypoglycemia induced fast [Ca2+]c increase. B, 10µM nifedipine, L-type Ca2+ 
channel blocker, was applied 5 minutes before imaging, and present in all solutions. 
C, 5 minutes before imaging, 1µM ω-conotoxin, N-type Ca2+ channel blocker, was 
applied to dishes and present in all solutions with 0.25% BSA. D. 9 minutes before 
imaging, combination of 10µM nifedipine and 1µM ω-conotoxin was applied to 
dishes and present in all solutions with 0.25% BSA. 
 
41 
Altered Ca2+ signaling in response to acute hypoglycemia by α-MSH 
Application of α-MSH during the drop of glucose changed Ca2+ signaling of 
αTC1-6 cells in response to acute hypoglycemia in the following respects: (1) 
Instead of the fast [Ca2+]c increase, a gradual increase of [Ca2+]c showed in the 
presence of α-MSH, comparable with a typical α-MSH response (Figure 17). (2) 
Removal of Ca2+ abolished the initial [Ca2+]c increase, and then there was a much 
smaller secondary [Ca2+]c increase, showing the ER Ca2+ store release (Figure 18). 
(3) Nifedipine abolished [Ca2+]c increase but ω-conotoxin did not, and the 
combination of these completely blocked [Ca2+]c increase (Figure 19). (4) α-MSH 
hyperpolarized αTC1-6 cells when glucose concentration dropped, while acute 
hypoglycemia, by itself, did not (Figure 20). (5) In the presence of α-MSH, insulin 











































Figure 17. α-MSH turned acute hypoglycemia-induced fast [Ca2+]c increase into a 
gradual increase. A, individual traces represent single cells. B, average trace of 44 




















































Figure 18. α-MSH caused smaller amplitude of acute hypoglycemia-induced CICR 
in Ca2+-free external solutions (Zero Ca2++ 100µM EGTA). A, individual traces 







































































Figure 19. Application of α-MSH altered the effects of VGCC blockers in acute 
hypoglycemia response. Traces represent the average of 40-60 cells plotted with 
error bars. A, Control: α-MSH induced gradual [Ca2+]c increase. B, 10µM 
nifedipine, L-type Ca2+ channel blocker, was applied 5 minutes before imaging, and 
present in all solutions. C, 10 minutes before imaging, 1µM ω-conotoxin, N-type 
Ca2+ channel blocker, was applied to dishes and present in all solutions with 0.25% 
BSA. D. 3 minutes before imaging, combination of 10µM nifedipine and 1µM 










































2mM glucose 60mM K+8mM glucose
2mM glucose/alpha-MSH 60mM K+8mM glucose 
Time (s)
Figure 20. Bisoxonol measurements showed the changes in cell membrane 
potential. Traces represent the average of 20-30 cells plotted with error bars. A, 
changes of membrane potential in response to acute hypoglycemia. B, changes of 





Figure 21. Insulin did not affect [Ca2+]c increase induced by α-MSH under 
 
hypoglycemia conditions. Traces represent the average of 40-50 cells plotted with 
error bars. A, control: α-MSH induced gradual [Ca2+]c increase under hypoglycemia. 














































Effects of acute hypoglycemia in [cAMP]c production 
FRET imaging was performed to determine whether change of glucose 
concentrations could affect [cAMP]c formation in αTC1-6 cells. Acute 
hypoglycemia was unable to cause the global increase of CFP/YFP fluorescence 
(Figure 22). Application of IBMX made a fluorescence increase detectable (Figure 
23). Drop of glucose together with IBMX increased [cAMP]c by 10%, and α-MSH 
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Figure 22. Acute hypoglycemia alone did not cause changes in FRET signals. A, 
individual traces represent single YFP-positive cells. Two out of 22 cells showed 












































Figure 23. Acute hypoglycemia and IBMX together induced increase in [cAMP]c. 
A, individual traces represent single YFP-positive cells. B, average trace of 52 cells 




















































Figure 24. α-MSH with IBMX enhanced acute hypoglycemia-induced [cAMP]c 
increase. A, individual traces represent single YFP-positive cells. B, average trace 





Role of α-MSH in glucagon secretion 
Since α-MSH stimulated cAMP production along with [Ca2+]c increase in 
αTC1-6 cells, it could also activate Ca2+-dependent glucagon secretion. αTC1-6 
cells were incubated within standard external solution containing 2mM glucose or 
8mM glucose (+/- 55nM α-MSH) for 10 or 30 minutes, and then cell media were 
collected and analyzed using glucagon EIA. Data were analyzed by unpaired 
student’s t-test for equal variance.  
In 10 minutes stimulation of 8mM glucose,  αTC1-6 cells incubated with 
α-MSH showed significant increase (P<0.05) in glucagon secretion (Figure 25). For 
those cells under hypoglycemic conditions, α-MSH caused increase in glucagon 
secretion in 10 minutes and significantly enhanced the amount of glucagon secreted 
in media (P<0.05) after 30 minutes (Figure 26). These indicated that α-MSH could 
stimulate glucagon secretion under euglycemia and hypoglycemia conditions. 
Surprisingly, acute hypoglycemia by itself did not stimulate glucagon secretion, but 
inhibit it by 30% (Figure 27). Considering the results that acute hypoglycemia 
caused large [Ca2+]c increase, in this case, elevated global [Ca2+]c is not necessarily 


























Figure 25. Effect of α-MSH on glucagon secretion in 8mM glucose standard 
external solutions. Data are expressed as means±SE (n=4 wells of αTC1-6 cells) 
























Figure 26. Effect of α-MSH on glucagon secretion in 2mM glucose standard 
external solutions. Data are expressed as means±SE (n=4 wells of αTC1-6 cells) 

























Figure 27. Effect of acute hypoglycemia on glucagon secretion in 8mM glucose 
standard external solutions. Data are expressed as means±SE (n=4 wells of αTC1-6 









This project combined intracellular [Ca2+]c imaging, FRET-based cAMP 
imaging, and glucagon secretion EIA to identify effect of α-MSH on cell signaling 
pathways in αTC1-6 cells. Consistent with the finding that peripheral injection of 
α-MSH increased plasma glucagon levels in mice (Hochgeschwender et al., 2003), 
application of α-MSH significantly increased glucagon secretion in αTC1-6 cells, 
compared with controls. Binding of α-MSH to MC4R caused increase of cAMP 
production, which is probably through Gα subunit-regulated AC activation. 
Nevertheless, [cAMP]c increase was only observed when α-MSH applied with PDE 
inhibitor IBMX, indicating the presence of clusters of enzymes such as AC and 
PDE, which could be anchored closely by AKAPs. α-MSH induced CICR mainly 
through L-type Ca2+ voltage gated channels, leading to Ca2+-dependent exocytosis. 




Acute hypoglycemia concentrations also induced [cAMP]c formation (cells 
were treated with IBMX) and CICR in αTC1-6 cells, but in this case, both L-type 
and N-type Ca2+ voltage gated channels equally contributed to the fast Ca2+ influx. 
Effects of α-MSH overrode acute hypoglycemia response and abolished inhibitory 
effect of insulin in acute hypoglycemia induced [Ca2+]c increase. Furthermore, 
α-MSH significantly increased glucagon secretion after 10 minutes stimulation in 
8mM glucose, and 30 minutes stimulation in 2mM glucose, respectively. Although 
acute hypoglycemia induced increase in both [Ca2+]c and [cAMP]c, glucagon 
secretion was actually inhibited. This is consistent with McGirr’s finding that 
glucose stimulates secretory response of αTC1-6 cells (McGirr et al., 2005), and 
possible reason could be the lack of insulin inhibition.   
Unresolved questions and future aims in cell signaling 
In αTC1-6 cells, α-MSH first stimulated increase in [cAMP]c then triggered 
CICR, but the interplay between cAMP and Ca2+ signal transduction cascades is 
still unclear. It has been reported that cAMP activates ryanodine receptor via 
Epac-dependent pathway and induced CICR in pancreatic β cells (Kang, 2003). ER 
Ca2+ store release was also stimulated by PKA phosphorylation on IP3R (Tsuboi, 
2003). Therefore, they may be both involved in α-MSH stimulated-glucagon 
secretion. Moreover, PCR results showed that αTC1-6 cells express several 
Ca2+-activated AC and PDE (Joachim, unpublished data), which may explain the 
role of elevated [Ca2+]c in acute hypoglycemia induced [cAMP]c production.  
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The finding that α-MSH slowly hyperpolarized αTC1-6 cells pointed to the 
role of K+ channels play in pancreatic α cell signaling pathway. Recently, Düfer and 
colleagues have demonstrated that Ca2+-activated K+ channel of intermediate 
conductance SK4 (KCa3.1, IK1) were identified to substantially contribute to slow 
hyperpolariztion. SK4 current deficiency caused increased Ca2+ action potential 
frequency and broadened single action potentials in pancreatic β cells of SK4 KO 
mice, and coincides with improved glucose tolerance (Düfer et al., 2009). In 
addition, it is known that G-protein could directly modulate K+ channel activity. Gβγ 
subunit, for example, directly binds to N- and C-termini of Kir3.1-4 channel, and 
activates Kir3 channels with PIP2, therefore, promoting K+ currents and further 
hyperpolarization (Xie et al., 2007). Considering that AC activator forskolin 
induced similar increase pattern in [Ca2+]c, but no hyperpolarization effect, it is 
possible that α-MSH induced opening of K+ channels via Gβγ subunits dissociated 
from activated MC4R.  
Although MC4R is known to be activated by α-MSH and ACTH, it was 
α-MSH that resumed glucagon secretion in POMC ko mice, but not ACTH 
(Hochgeschwender et al., 2003). The mechanism underlying this discrepancy is still 
unclear. If ACTH activated MC4R signaling goes through different pathways in 
αTC1-6 cells, which is not involved in glucagon secretion, it will explain the earlier 
results from POMC ko mice study. However, there is good chance that application 
of ACTH also induces increase in [Ca2+]c, [cAMP]c, and glucagon secretion. In that 
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case, other possibilities should be considered, such as the sources of α-MSH and 
ACTH, and their effects on pancreatic δ cells, which is another pancreatic cell type 
that expresses MC4R (Lumsden, MS thesis 2008).  
Current work that has been done by this project was performed on mice 
pancreatic α cell line, αTC1-6 cells, and therefore it pays to investigate the effect of 
α-MSH on primary α-cells as well as intact islets. According to Theresa Lumsden’s 
QPCR results, MC4R expression levels are much higher in primary α cells than in 
αTC1-6 cells (Lumsden, MS thesis 2008). In addition, α cells are highly sensitive to 
secretory products from β cells and γ cells, including insulin, zinc, SST, and so on, 
which could also affect α-MSH response. Future studies based on the intact islet 
measurements will provide us more evidence towards physiological scenario. 
Unresolved questions and future aims in the role of α-MSH and MC4R 
For decades, the interaction between α-MSH and MC4R has been well 
studied, but mainly focused on regulation of energy homeostasis and potential 
treatments for obesity. As a result, ko mice models and antisense oligonucleotides 
approaches have been well developed (Butler and Cone, 2002). Unlike POMC ko 
mice, MC4R ko mice are also diabetic. Pancreatic β cell hyperplasia and 
hyperinsulinemia are observed from an early age (Huszar et al., 1997; Warbritton et 
al. 1994). In CNS, chronic infusions of α-MSH and antisense oligonucleotides that 
suppress MC4R expression were successfully performed in wild type mice. It was 
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found that application of α-MSH in third ventricle increased insulin sensitivity and 
inhibition of hypothalamic MC4R expression reversed it (Obici et al., 2001). 
Similar approaches could be adapted into the studies of mice pancreatic islets to 
examine the role of α-MSH on glucose homeostasis in vivo. 
The other important issue is the source of α-MSH that could stimulate 
pancreatic α cells in vivo. There are at least three possibilities in terms of the origin 
of α-MSH: (1) from the intermediate lobe of pituitary via blood circulation; (2) 
from neurons that directly innervate pancreatic islets; (3) from paracrine or 
autocrine signals circulating inside of islets. Based on PCR analysis, although the 
specific cell type is still unknown, pancreatic islet cells did express POMC gene 
(Lumsden, MS thesis 2008). Again, antisense oligonucleotides approach could be 
used to examine which cell type is producing α-MSH in islets. 
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